ÂÜÀòÂÒÂ×

Bob Shepler has been a corporate transactions specialist and investor since 1978, with a focus on strategic M&A transactions. Bob and Matt Mackowski partnered together in 1991 to form Telegraph Hill Partners’ (THP) predecessor, focused on investing in private healthcare companies. During his career, Bob has served on numerous company boards and has represented THP on the boards of various life science and healthcare companies including Kinetikos Medical, AcroMetrix, Agena Bioscience, Aurora Discovery, Applied Precision, LDR Spine, Estech, RareCyte, Sage Labs, and Vidacare. Prior to THP, Bob was an officer with Merrill Lynch & Co. Bob received a BA from Duke University and an MBA from New York University.